Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Beam Therapeutics (BEAM) Return on Assets (2020 - 2025)

Historic Return on Assets for Beam Therapeutics (BEAM) over the last 6 years, with Q3 2025 value amounting to 0.31%.

  • Beam Therapeutics' Return on Assets fell 1900.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of 0.29% for FY2024, which is 2000.0% down from last year.
  • Beam Therapeutics' Return on Assets amounted to 0.31% in Q3 2025, which was down 1900.0% from 0.28% recorded in Q2 2025.
  • In the past 5 years, Beam Therapeutics' Return on Assets registered a high of 0.09% during Q4 2023, and its lowest value of 0.53% during Q1 2021.
  • Its 5-year average for Return on Assets is 0.24%, with a median of 0.22% in 2022.
  • In the last 5 years, Beam Therapeutics' Return on Assets surged by 3800bps in 2022 and then tumbled by -2300bps in 2024.
  • Beam Therapeutics' Return on Assets (Quarter) stood at 0.27% in 2021, then increased by 23bps to 0.21% in 2022, then skyrocketed by 56bps to 0.09% in 2023, then tumbled by -258bps to 0.33% in 2024, then grew by 6bps to 0.31% in 2025.
  • Its Return on Assets was 0.31% in Q3 2025, compared to 0.28% in Q2 2025 and 0.3% in Q1 2025.